Kenneth Maiese
#128,497
Most Influential Person Now
Researcher
Kenneth Maiese's AcademicInfluence.com Rankings
Kenneth Maieseengineering Degrees
Engineering
#4311
World Rank
#5501
Historical Rank
Biomedical Engineering
#259
World Rank
#266
Historical Rank
Applied Physics
#1020
World Rank
#1045
Historical Rank
Kenneth Maiesebiology Degrees
Biology
#8301
World Rank
#11355
Historical Rank
Neuroscience
#1138
World Rank
#1180
Historical Rank
Download Badge
Engineering Biology
Kenneth Maiese's Degrees
- PhD Biomedical Engineering University of California, Berkeley
- Masters Biomedical Engineering University of California, Berkeley
- Bachelors Biomedical Engineering University of California, Berkeley
Why Is Kenneth Maiese Influential?
(Suggest an Edit or Addition)Kenneth Maiese's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
- New avenues of exploration for erythropoietin. (2005) (533)
- Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease (2005) (517)
- Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases (2002) (384)
- Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia (1994) (326)
- Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathways (2003) (228)
- The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. (2007) (226)
- Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. (2007) (208)
- Hematopoietic Factor Erythropoietin Fosters Neuroprotection through Novel Signal Transduction Cascades (2002) (199)
- Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. (2005) (196)
- mTOR: on target for novel therapeutic strategies in the nervous system. (2013) (195)
- The Vitamin Nicotinamide: Translating Nutrition into Clinical Care (2009) (191)
- Mechanistic insights into diabetes mellitus and oxidative stress. (2007) (184)
- New Insights for Oxidative Stress and Diabetes Mellitus (2015) (173)
- Erythropoietin in the brain: can the promise to protect be fulfilled? (2004) (173)
- Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin (2003) (171)
- Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. (2003) (165)
- Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity (1993) (163)
- OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. (2008) (162)
- Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8 (2003) (160)
- Life Span Extension and Neuronal Cell Protection by Drosophila Nicotinamidase* (2008) (159)
- The Wnt signaling pathway: aging gracefully as a protectionist? (2008) (157)
- Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease (2005) (151)
- Winding through the WNT pathway during cellular development and demise. (2006) (150)
- The NAD+ Precursor Nicotinamide Governs Neuronal Survival During Oxidative Stress Through Protein Kinase B Coupled to FOXO3a and Mitochondrial Membrane Potential (2004) (140)
- Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders (2010) (138)
- Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. (2016) (137)
- SIRT1: new avenues of discovery for disorders of oxidative stress (2012) (133)
- Angiogenesis and plasticity: role of erythropoietin in vascular systems. (2002) (125)
- Targeting disease through novel pathways of apoptosis and autophagy (2012) (122)
- The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways. (2005) (120)
- Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. (2003) (118)
- Erythropoietin Requires NF-κB and its Nuclear Translocation to Prevent Early and Late Apoptotic Neuronal Injury During β-Amyloid Toxicity (2005) (118)
- Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide. (2006) (117)
- Erythropoietin involves the phosphatidylinositol 3‐kinase pathway, 14‐3‐3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity (2007) (117)
- Nicotinamide Modulates Mitochondrial Membrane Potential and Cysteine Protease Activity during Cerebral Vascular Endothelial Cell Injury (2002) (116)
- Erythropoietin and oxidative stress. (2008) (115)
- Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies (2008) (114)
- Prevention of Nitric Oxide-Induced Neuronal Injury Through the Modulation of Independent Pathways of Programmed Cell Death (2000) (111)
- Erythropoietin on a Tightrope: Balancing Neuronal and Vascular Protection between Intrinsic and Extrinsic Pathways (2004) (110)
- A “FOXO” in sight: Targeting Foxo proteins from conception to cancer (2009) (110)
- Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL (2012) (109)
- Oxidative stress: Biomarkers and novel therapeutic pathways (2010) (109)
- Reduction in Focal Cerebral Ischemia by Agents Acting at Imidazole Receptors (1992) (107)
- Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons (1994) (106)
- Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. (2005) (105)
- Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death (2000) (104)
- Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin (2012) (104)
- Targeting cardiovascular disease with novel SIRT1 pathways. (2012) (103)
- Raves and risks for erythropoietin. (2008) (96)
- Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. (2007) (96)
- Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity (2003) (95)
- Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. (2010) (93)
- Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress. (2011) (92)
- AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9. (2004) (91)
- Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade (2012) (89)
- Nitric oxide induction of neuronal endonuclease activity in programmed cell death. (1999) (86)
- Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia (1993) (85)
- "Sly as a FOXO": new paths with Forkhead signaling in the brain. (2007) (84)
- A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR. (2012) (84)
- The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. (2007) (83)
- Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. (2007) (83)
- Vital elements of the Wnt-Frizzled signaling pathway in the nervous system. (2005) (82)
- The Metabotropic Glutamate Receptor System Protects against Ischemic Free Radical Programed Cell Death in Rat Brain Endothelial Cells (2001) (82)
- Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer. (2017) (81)
- Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia (1993) (81)
- Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. (2008) (81)
- Mammalian target of rapamycin signaling in diabetic cardiovascular disease (2012) (81)
- Cardiovascular disease and mTOR signaling. (2011) (80)
- Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. (2011) (79)
- Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. (2004) (78)
- Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection (2000) (78)
- Neuroprotection of Lubeluzole Is Mediated Through the Signal Transduction Pathways of Nitric Oxide (1997) (78)
- Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress. (2006) (77)
- FoxO Proteins in the Nervous System (2015) (76)
- Erythropoietin: cytoprotection in vascular and neuronal cells. (2003) (75)
- Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. (2004) (75)
- Cellular Mechanisms of Protection by Metabotropic Glutamate Receptors During Anoxia and Nitric Oxide Toxicity (1996) (75)
- Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress. (2010) (73)
- FoxO proteins: cunning concepts and considerations for the cardiovascular system. (2009) (73)
- Erythropoietin: New Directions for the Nervous System (2012) (72)
- Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death. (1999) (71)
- EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes. (2011) (71)
- Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. (2004) (71)
- Metabotropic Glutamate Receptors Prevent Programmed Cell Death through the Modulation of Neuronal Endonuclease Activity and Intracellular pH (1999) (71)
- Neuroprotection by Peptide Growth Factors against Anoxia and Nitric Oxide Toxicity Requires Modulation of Protein Kinase C (1995) (70)
- Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus. (2008) (70)
- WISP1: Clinical insights for a proliferative and restorative member of the CCN family. (2014) (69)
- A fork in the path: Developing therapeutic inroads with FoxO proteins. (2009) (69)
- Taking aim at Alzheimer's disease through the mammalian target of rapamycin (2014) (69)
- Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways. (2010) (68)
- Direct Temporal Analysis of Apoptosis Induction in Living Adherent Neurons (1999) (68)
- mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. (2005) (67)
- Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of Glycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB (2006) (67)
- The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. (2009) (66)
- Driving neural regeneration through the mammalian target of rapamycin (2014) (64)
- PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection (2012) (63)
- Acquired central dyschromatopsia: Analysis of a case with preservation of color discrimination (1989) (63)
- Translating cell survival and cell longevity into treatment strategies with SIRT1. (2011) (61)
- The "O" class: crafting clinical care with FoxO transcription factors. (2009) (60)
- The Tyrosine Phosphatase SHP2 Modulates MAP Kinase p38 and Caspase 1 and 3 to Foster Neuronal Survival (2003) (60)
- The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. (2001) (60)
- Clever cancer strategies with FoxO transcription factors (2008) (59)
- The Metabotropic Glutamate System Promotes Neuronal Survival through Distinct Pathways of Programmed Cell Death (2000) (58)
- Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL. (2012) (58)
- T‐cell lymphoma in the CNS (1989) (58)
- Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. (2004) (57)
- Therapeutic promise and principles Metabotropic glutamate receptors (2008) (56)
- The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment (2020) (55)
- Metabotropic glutamate receptor subtypes independently modulate neuronal intracellular calcium (1999) (55)
- Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease (2015) (55)
- FOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling (2010) (55)
- Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. (2006) (55)
- WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy. (2012) (55)
- Metabotropic glutamate receptors prevent nitric oxide‐induced programmed cell death (1997) (54)
- FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus. (2015) (54)
- Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. (2005) (54)
- Novel directions for diabetes mellitus drug discovery (2013) (54)
- Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease (2016) (53)
- SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer. (2015) (53)
- Cutting through the complexities of mTOR for the treatment of stroke. (2014) (52)
- Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3. (2006) (51)
- Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia. (2012) (50)
- FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis. (2009) (50)
- New strategies for Alzheimer disease and cognitive impairment (2009) (49)
- Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus (2011) (49)
- Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade (1994) (47)
- Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR (2016) (45)
- mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus. (2015) (45)
- The dynamics of cellular injury: transformation into neuronal and vascular protection. (2001) (45)
- Disease onset and aging in the world of circular RNAs (2016) (43)
- Forkhead transcription factors: new considerations for alzheimer’s disease and dementia (2016) (43)
- WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1. (2012) (43)
- Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats (1995) (42)
- Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better? (2005) (41)
- Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. (2003) (41)
- Erythropoietin and diabetes mellitus. (2015) (41)
- Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology (2009) (41)
- Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia. (2012) (40)
- Regeneration in the nervous system with erythropoietin. (2016) (38)
- Programming apoptosis and autophagy with novel approaches for diabetes mellitus. (2015) (37)
- Diabetic stress: new triumphs and challenges to maintain vascular longevity (2008) (37)
- Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling? (2008) (36)
- Group I metabotropic receptors down-regulate nitric oxide induced caspase-3 activity in rat hippocampal neurons (1999) (36)
- Forkhead transcription factors. (2009) (34)
- Marking the onset of oxidative stress (2009) (34)
- Intra-arterial cisplatin--associated optic and otic toxicity. (1992) (34)
- Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
- Diabetes mellitus: channeling care through cellular discovery. (2010) (33)
- From the bench to the bedside: the molecular management of cerebral ischemia. (1998) (32)
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
- Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss. (2017) (30)
- Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin. (2017) (30)
- Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1 (2020) (29)
- Nicotinamide: A Nutritional Supplement that Provides Protection Against Neuronal and Vascular Injury. (2001) (29)
- Effect of acute and chronic arecoline treatment on cerebral metabolism and blood flow in the conscious rat (1994) (28)
- The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders. (2018) (27)
- The bright side of reactive oxygen species: lifespan extension without cellular demise (2016) (27)
- Cell cycle induction in post-mitotic neurons proceeds in concert with the initial phase of programmed cell death in rat (2001) (26)
- Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease. (2017) (26)
- Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy. (2016) (25)
- Critical Temporal Modulation of Neuronal Programmed Cell Injury (2000) (25)
- Stem cell guidance through the mechanistic target of rapamycin. (2015) (25)
- MicroRNAs and SIRT1: A Strategy for Stem Cell Renewal and Clinical Development? (2015) (24)
- Choices and outcomes (2009) (23)
- Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors. (2018) (22)
- Targeting erythropoietin for chronic neurodegenerative diseases (2013) (20)
- New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR. (2020) (20)
- Forkhead transcription factors : vital elements in biology and medicine (2009) (19)
- Elucidating Neuronal and Vascular Injury Through the Cytoprotective Agent Nicotinamide (2001) (19)
- Group I metabotropic glutamate receptors prevent endothelial programmed cell death independent from MAP kinase p38 activation in rat (2001) (17)
- Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and Rho/Rock (2019) (17)
- Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways (2019) (17)
- Reducing Oxidative Stress and Enhancing Neurovascular Longevity During Diabetes Mellitus (2010) (15)
- Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease. (2019) (15)
- Neurovascular Medicine: Pursuing Cellular Longevity for Healthy Aging (2009) (15)
- Charting a course for erythropoietin in traumatic brain injury. (2016) (14)
- TRANSFORMATION INTO TREATMENT: NOVEL THERAPEUTICS THAT BEGIN WITHIN THE CELL (2003) (14)
- Therapeutic targets for cancer: Current concepts with PI 3-K, Akt, & mTOR (2013) (13)
- Erythropoietin and Cancer—Reply (2005) (13)
- Mammalian target of rapamycin Hitting the bull ’ seye for neurological disorders (2014) (11)
- The many facets of cell injury: angiogenesis to autophagy. (2012) (11)
- Aging and Age-Related Disorders (2010) (11)
- Protein kinase C modulates the protective ability of peptide growth factors during anoxia. (1994) (11)
- MicroRNAs for the Treatment of Dementia and Alzheimer's Disease. (2019) (11)
- Ringing in the New Year (2010) (11)
- High anxiety: recognizing stress as the stressor. (2009) (10)
- Clinical study of a new antimetastatic compound, Nafazatrom (Bay g 6575). Effects on platelet consumption and monocyte prostaglandin production in patients with advanced cancer (1986) (9)
- The Metabotropic Glutamate Receptor System: G-Protein Mediated Pathways that Modulate Neuronal and Vascular Cellular Injury (2002) (9)
- Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease. (2020) (9)
- Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus (2020) (9)
- Neuronal Activity, Mitogens, and mTOR: Overcoming the Hurdles for the Treatment of Glioblastoma Multiforme (2015) (8)
- Neuronal Survival: Cellular and Molecular Pathways of Protection a (1997) (8)
- Nicotinamide: Oversight of Metabolic Dysfunction through SIRT1, mTOR, and Clock Genes. (2020) (8)
- Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders. (2021) (7)
- A novel prescription for Alzheimer's disease: targeting hypercoagulable states. (2015) (6)
- Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways (2021) (6)
- Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19. (2020) (6)
- Comprar Aging and age-related disorders (oxidative stress in applied basic research and clinical practice) | Bondy, S. | 9781607616016 | Humana Press (2010) (5)
- Autophagy to the Rescue. (2017) (5)
- Healing the Heart with Sirtuins and Mammalian Forkhead Transcription Factors. (2019) (5)
- Coma Following Cardiac Arrest: A Review of the Clinical Features, Management, and Prognosis (1988) (5)
- Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm (2021) (5)
- Paring down obesity and metabolic disease by targeting inflammation and oxidative stress. (2015) (4)
- Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR. (2021) (4)
- MicroRNAs and Stem Cells to the Rescue. (2015) (4)
- Targeting conserved pathways: mitochondrial dysfunction and beyond. (2012) (4)
- Dissecting the Biological Effects of Isoflurane through the Mechanistic Target of Rapamycin (mTOR) and microRNAs (miRNAs). (2020) (4)
- From the Editors Perspective: Rational Approaches for Radical Entities (2005) (4)
- Dampening the Progression of Dementia. (2018) (4)
- "Connecting the dots" from blood brain barrier dysfunction to neuroinflammation and Alzheimer's disease. (2014) (4)
- Neuronal Degeneration and Regeneration: From Basic Mechanisms to Prospects for Therapy. F. W. Van Leeuwen , A. Salehi , R. J. Giger , A. J. G. D. Holtmaat, J. Verhaagen (2000) (3)
- Heightened Attention for Wnt Signaling in Diabetes Mellitus. (2020) (3)
- Introduction from the Editor-In-Chief (2004) (3)
- Late Onset Alzheimer's Disease: Novel Clinical Prospects for the Future. (2017) (3)
- Sirtuins in metabolic disease: innovative therapeutic strategies with SIRT1, AMPK, mTOR, and nicotinamide (2021) (3)
- Brain Disease, Organic (2002) (3)
- A Sweeping Role for MicroRNAs in Neuronal Disease, Vascular Disorders, and as Prognostic Indicators. (2018) (3)
- "Tripping out" with the TRP superfamily and TRPV1 for novel neuroprotection. (2014) (3)
- Preserving Brain Function During Development and Aging with Erythropoietin. (2019) (3)
- Epigenetics in the cerebrovascular system: changing the code without altering the sequence. (2014) (3)
- The challenges for drug development: cytokines, genes, and stem cells. (2012) (3)
- Turning up the pressure on vascular disease. (2014) (2)
- Editors Perspective (Throwing Caution to the Wnts) (2012) (2)
- Addressing Alzheimer's Disease and Cognitive Loss Through Autophagy. (2020) (2)
- Novel treatment strategies for neurodegenerative disease with sirtuins (2021) (2)
- Non-coding RNAs: Cracking the Code for Clinical Disease. (2017) (2)
- Novel Stem Cell Strategies with mTOR (2016) (2)
- A balancing act for oxidative stress (2010) (2)
- Alcohol Use Disorder and Dementia: Critical Mechanisms for Cognitive Loss. (2021) (2)
- Sleep Disorders, Neurodegeneration, Glymphatic Pathways, and Circadian Rhythm Disruption. (2021) (2)
- New Challenges and Strategies for Cardiac Disease: Autophagy, mTOR, and AMP-Activated Protein Kinase. (2020) (2)
- Inflammatory glial cells of the nervous system: assistants or assassins? (2005) (2)
- Impacting neuronal and vascular cellular signal transduction through the metabotropic glutamate receptor system (2005) (2)
- Metabolic Clues: Novel Directives for Broad Treatment Strategies (2010) (1)
- Membership of the ESM (2002) (1)
- From the editor's perspective: unlocking the secrets to cell survival and longevity. (2005) (1)
- Releasing the Genie in the Bottle: Molecular Signaling with Hydrogen Sulfide. (2019) (1)
- Exciting news from the messenger. (2007) (1)
- Dual Pathways of Free Radical Injury in Vascular Endothelial Cells: Loss of Nuclear DNA Integrity and Membrane Asymmetry During Enhanced Cysteine Protease Activity (2001) (1)
- Regulation of Neuronal Vulnerability to Ischemia by Peptide Growth Factors and Intracellular Second Messenger Systems: The Role of Protein Kinase C and the cAMP Dependent Protein Kinase (1995) (1)
- Dissecting the Mechanisms of Thrombogenesis and Atherosclerosis for Neurodegenerative Disorders. (2016) (1)
- Throwing caution to the Wnts. (2012) (1)
- Cellular balance, genes, and the Huang Ti Nei Ching Su Wen. (2006) (1)
- "Micromanaging" Glioblastoma Multiforme: The Potential of MicroRNAs, Circular RNAs, and the Hippo Pathway as Novel Treatment Strategies. (2018) (1)
- A fork in the path (2009) (1)
- Heal thyself (2010) (1)
- New Directions for Dementia. (2018) (1)
- Novel Pathways of Autophagy for the Treatment of Nervous System Disorders (2018) (1)
- Mitochondria: "Mood Altering Organelles" that Impact Disease Throughout the Nervous System. (2015) (1)
- The Oversight of Circadian Clock Genes for the Detection, Prevention, and Treatment of COVID-19 Infection. (2021) (0)
- List of contributors (2021) (0)
- Competing forces of nature (2009) (0)
- From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease (2004) (0)
- Editors & Editorial Board (2012) (0)
- Editor's Perspective (Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond) (2013) (0)
- Wnt Signaling and WISP1 (CCN4): Critical Components in Neurovascular Disease, Blood Brain Barrier Regulation, and Cerebral Hemorrhage. (2022) (0)
- A Common Link in Neurovascular Regenerative Pathways: Protein Kinase B (Akt). (2022) (0)
- Tolerance: a virtue during times of stress. (2010) (0)
- Brain Disease, Organic: Presentation, Diagnosis, and Novel Strategies (2016) (0)
- Environmental stimulus package (2009) (0)
- Oxidative stress: Biology and biomarkers in the vascular system during (2011) (0)
- Harvesting new therapeutic avenues with stem cell applications. (2013) (0)
- The Immune System and the Brain: Crosstalk with a Broad Impact From Host Defense to Cognition. (2016) (0)
- Biomarkers and Cellular Signal Detection for Alzheimer's Disease, Stroke, and Immune System Mediated Disorders. (2016) (0)
- From biomarkers to cytokine-like hormones: uncovering new directives for cognitive loss and Alzheimer's disease. (2013) (0)
- Erythropoietin and cancer [4] (multiple letters) (2005) (0)
- Handbook of Experimental Neurology: Targeting molecular constructs of cellular function and injury through in vitro and in vivo experimental models (2006) (0)
- Reacting to stress: radical cellular pathways for novel drug development. (2013) (0)
- Compromise and care of the brain's compartments: the quintessence of the neurovascular unit. (2006) (0)
- G-Protein Mediated Metabotropic Receptors Offer Novel Avenues in Neuronal and Vascular Cells for Cytoprotective Strategies (2003) (0)
- Selective Ischemic Nuclear DNA Cleavage is Dependent upon the Free Radical Generation of Caspase-3 and the Specific Induction of Neuronal Endonuclease Genes (1999) (0)
- detailed understanding of the cellular mechanisms that govern erythropoietin's roles in both cytoprotection and cytotoxicity. (2017) (0)
- Nordic Microcirculation Society (2002) (0)
- Just in the Nick of Time: Targeting Acute versus Chronic Disease (2010) (0)
- Regeneration in the nervous system with erythropoietin. (2016) (0)
- Medicine's "Da Vinci Code": Deciphering the intricate origins of clinical neurovascular pathology. (2006) (0)
- Pyroptosis, Apoptosis, and Autophagy: Critical Players of Inflammation and Cell Demise in the Nervous System. (2022) (0)
- Early Molecular Mechanisms for the Induction of Neuronal Membrane Asymmetry and Genomic DNA Cleavage (2002) (0)
- Transcript of Live Discussion: The Cell Cycle in Alzheimer's Disease: Let's Unite Around Division (2003) (0)
- Novel Strategies for Neurovascular Longevity During Aging (2010) (0)
- Inaugural Message from the Founding Editor-in-Chief (2015) (0)
- High anxiety (2009) (0)
- Book Review:Cerebral Ischemia: Molecular and Cellular Pathophysiology Wolfgang Walz (2000) (0)
- Experimental models of discovery: prediction and protection must proceed "hand-in-hand". (2007) (0)
- Apolipoprotein-ε4 allele (APOE-ε4) as a Mediator of Cognitive Loss and Dementia in Long COVID-19. (2022) (0)
- Knowing When to Trust Your Gut: The Intimate Relationship Between Neurodegenerative Diseases and the Brain-Gut Axis. (2019) (0)
- Contents Vol. 13, 2004 (2004) (0)
- Tissue sites of EPO and its biological functions EPO production and expression sites Biological function Kidney Erythropoiesis Liver Protection and erythropoiesis Kupfer cells Hepatocytes Uterus Proliferation Brain Neurons (2008) (0)
- Vascular Patency: A Biomarker and Clinical Target Quantified with High Resolution MRI and Novel Cellular Pathways. (2016) (0)
- Neuronal and Vascular Plasticity (2003) (0)
- Timing is Everything (2005) (0)
- Peripheral Neuropathy: An Early Indication for Systemic Disease that Involves the Mechanistic Target of Rapamycin (mTOR). (2023) (0)
- Therapeutic promise and principles (2008) (0)
- Comprar Neurovascular Medicine Pursuing Cellular Longevity for Healthy Aging | Maiese, Kenneth | 9780195326697 | Oxford University Press (2009) (0)
- A path to development or demise (2006) (0)
- Biomarkers for Parkinson's Disease and Neurodegenerative Disorders: A Role for Non-coding RNAs. (2022) (0)
- Enriching one's environment in the face of cognitive and functional loss. (2012) (0)
- From the Editors Perspective:New Directions and New Sources for Stem Cells [Hot Topic: Stem Cells (Guest Editor: Feng C. Zhou)] (2004) (0)
- Releasing the Genie in the Bottle: Molecular Signaling with Hydrogen Sulfide (2019) (0)
- A Piece of the ROCK: A Critical Role for Rho Kinases in the Nervous System. (2019) (0)
- Knowing When to Trust Your Gut: The Intimate Relationship Between Neurodegenerative Diseases and the Brain-Gut Axis. (2019) (0)
- The metabotropic glutamate receptor system: a novel pathway for the molecular protection against microvascular programmed cell death (2002) (0)
- Advances in Experimental Medicine and Biology: Preface (2009) (0)
- From the Editors Perspective: Aquaporins to Apoptosis (2004) (0)
- Subject Index Vol. 13, 2004 (2004) (0)
- The Impact of Sirtuins, Erythropoietin, and Hypoxia-Inducible Factor-1 on Neurovascular Disease. (2021) (0)
- List of contributors (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kenneth Maiese?
Kenneth Maiese is affiliated with the following schools:
